- Home
- » Tags
- » Telapristone
Top View
- Epidemiology and Management of Uterine Fibroids Emma Giuliani1, Sawsan As-Sanie2, Erica E
- CDB-4124, a Progesterone Receptor Modulator, Inhibits Mammary Carcinogenesis by Suppressing Cell Proliferation and Inducing Apoptosis
- 90 Years of Progesterone: Selective Progesterone Receptor Modulators in Gynaecological Therapies
- Abnormal Uterine Bleeding1,2,3
- A Six-Month Baboon Study Comparing Two Anti-Hormones Given Separately and Simultaneously
- Progesterone Receptor Modulators in Breast Cancer
- Management of Women with Fibroids- Why We Need New Options
- International Nonproprietary Names for Pharmaceutical Substances (INN)
- Progesterone Receptor Blockade in Human Breast Cancer Cells Decreases Cell Cycle Progression Through G2/M by Repressing G2/M Genes Susan E
- Hormonal Therapy for Endometriosis: from Molecular Research to Bedside
- Progesterone Receptor Antagonists Reverse Stem Cell Expansion And
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Progesterone Action in Breast, Uterine, and Ovarian Cancers
- Research Journal of Pharmaceutical, Biological and Chemical Sciences
- Selective Progesterone Receptor Modulators in Early Stage Breast
- Uterine Fibroids: an Update on Current and Emerging Medical Treatment Options
- 2011 Medicines in Development for Women
- Biological and Clinical Impact of Imbalanced Progesterone Receptor Isoform Ratios in Breast Cancer
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Bioinformatics Analysis of Essential Genes in NF1 and CDKN2A Null Cancer Cell Lines
- Leiomyomas (1 of 6)
- Medical Treatments for Endometriosis-Associated Pelvic Pain
- Endométriose : Briser Le Tabou Et Améliorer La Prise En Charge Apport Du Pharmacien D’Officine
- Selective Progesterone Receptor
- Ulipristal Acetate in Healthy Premenopausal
- Oup Humupd Dmy020 577..598 ++
- Progesterone and Progesterone Receptor Modulators in the Management of Symptomatic Uterine Fibroids European Journal of Obstetri
- A New Medical Option for Termination of Pregnancy: Introducing Mifegymiso
- Options for Management of Uterine Fibroids
- Progesterone Receptor Isoforms, Agonists and Antagonists Differentially Reprogram Estrogen Signaling
- Risks, Problems, and Complications in Diagnosis and Therapy of Adenomyosis and Myomata
- Uterine Fibroid Management: from the Present to the Future